Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis

As part of “liquid biopsy,” lots of literature indicated the potential diagnostic value of circulating cell-free DNA (cfDNA) in the management of prostate cancer (PCa). However, the literature on the accuracy of cfDNA detection in PCa has been inconsistent. Hence, we performed this meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Changqing, Luo, Changliang, Hu, Wei, Ding, Xu, Yuan, Chunhui, Wang, Fubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059577/
https://www.ncbi.nlm.nih.gov/pubmed/27766004
http://dx.doi.org/10.1155/2016/3825819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059577/
https://www.ncbi.nlm.nih.gov/pubmed/27766004
http://dx.doi.org/10.1155/2016/3825819

Ejemplares similares